登录  注册

肿瘤学学术中心

2016 ASCO临床实践指南:女性早期浸润性乳腺癌患者使用生物标志物指导辅助性全身治疗

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women with Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

发布时间:2016-2-19

This guideline provides evidence-based recommendations to practicing oncologists and other stakeholders on the appropriate use of breast tumor biomarker assay results to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer with known hormone receptor (estrogen and progesterone receptors [ER/PgRs]) and human epidermal growth factor receptor 2 [HER2]) status. In an era of great interest in personalized, precision medicine, the role of tumor biomarker assays in guiding clinical care has taken on even greater importance than in the past.

全文地址:
顶一下(0

发表评论

 热门指南  more

学科影响因子排名more

 会议回顾 more

  • 中文版启动会暨第一次编委会议 圆满...

  • 【专题】2015年美国临床肿瘤大会...

  • 多模式防治 改善肿瘤患者生存

 热门病例 more

Elsevier中国网站
爱唯医学网
爱思唯尔科技部
NursingChina
柳叶刀中文版
大通医疗决策
医大爱思唯尔
Elsevier医学数据库
CK
Journal Consult
Procedures_CONSULT
ClinicalPharmacologyLogo
3D Interact Anatomy
Mosby’s Nursing Consult
NursingChina
Science Direct